Back to Search Start Over

Abaloparatide.

Authors :
Chaplin, Steve
Source :
Prescriber. Nov2024, Vol. 35 Issue 6, p27-28. 2p.
Publication Year :
2024

Abstract

Abaloparatide stimulates osteoblast activity and is licensed for treating postmenopausal women with fracture risk. Here, we discuss the clinical evidence for benefit and also the drug adverse effect profile. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09596682
Volume :
35
Issue :
6
Database :
Academic Search Index
Journal :
Prescriber
Publication Type :
Academic Journal
Accession number :
181679303
Full Text :
https://doi.org/10.1002/psb.2160
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details